s6y Aligos Therapeutics, Inc. S-8

Aligos Therapeutics, Inc. S-8, filed Mar 10, 2022: EX-FILING FEES

Exhibit 107.1

Calculation of Filing Fee Table

Form S-8

(Form Type)

Aligos Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

Security Type

Security
Class

Title

Fee

Calculation

Rule

Amount
Registered(1)

Proposed

Maximum
Offering
Price Per
Unit

Maximum
Aggregate

Offering

Price

Fee

Rate

Amount of
Registration
Fee
Equity Common
stock,
$0.0001
par value
per share
Rule 457(c)
and Rule
457(h)
2,134,511(2) $2.38(3) $5,069,463.63 $0.0000927 $469.94
Equity Common
stock,
$0.0001
par value
per share
Rule 457(c)
and Rule
457(h)
426,902(4) $2.38(3) $1,013,892.25 $0.0000927 $93.99
Total Offering Amounts   $6,083,355.88   $563.93
Total Fee Offsets       $-(5)
Net Fee Due       $563.93

 

  (1)

Pursuant to Rule 416 of the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s Common Stock (“Common Stock”) that become issuable under the Registrant’s 2020 Incentive Award Plan (the “2020 Plan”) and the Registrant’s 2020 Employee Stock Purchase Plan (“ESPP”) by reason of any stock dividend, stock split or similar transaction effected without the receipt of consideration that results in an increase in the number of the outstanding shares of Common Stock.

 

  (2)

Represents shares of Common Stock that were automatically added to the shares authorized for issuance under the 2020 Plan on January 1, 2022 pursuant to an “evergreen” provision contained in the 2020 Plan. Pursuant to such provision, the number of shares of Common Stock reserved for issuance pursuant to awards under such plan are increased on the first day of each year beginning in 2021 and ending in 2030 equal to the lesser of (A) five percent of the shares of stock outstanding on the last day of the immediately preceding fiscal year and (B) such smaller number of shares of stock as determined by the Registrant’s Board; provided, however, that no more than 32,672,731 shares of stock may be issued upon the exercise of incentive stock options.

 

  (3)

Estimated in accordance with Rule 457(h) solely for the purpose of calculating the registration fee on the basis of $2.38 per share, which is the average of the high and low prices of Common Stock on March 4, 2022, as reported on the Nasdaq Global Select Market.

 

  (4)

Represents shares of Common Stock that were automatically added to the shares authorized for issuance under the ESPP on January 1, 2022 pursuant to an “evergreen” provision contained in the ESPP. Pursuant to such provision, the number of shares of Common Stock reserved for issuance under such plan are increased on the first day of each year beginning in 2021 and ending in 2030 equal to the lesser of (A) one percent of the shares of stock outstanding on the last day of the immediately preceding fiscal year and (B) such smaller number of shares of stock as determined by the Registrant’s Board; provided, however, no more than 6,534,546 shares of stock may be issued under the ESPP.

 

  (5)

The Registrant does not have any fee offsets.